Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof

Details for Australian Patent Application No. 2007293662 (hide)

Owner Crucell Holland B.V.

Inventors De Kruif, Cornelis Adriaan; Van Den Brink, Edward Norbert; Throsby, Mark

Agent Davies Collison Cave

Pub. Number AU-B-2007293662

PCT Pub. Number WO2008/028946

Priority 06120316.2 07.09.06 EP; 60/842,930 07.09.06 US; 07111235.3 28.06.07 EP; 06120644.7 14.09.06 EP; 06125107.0 30.11.06 EP

Filing date 6 September 2007

Wipo publication date 13 March 2008

Acceptance publication date 4 October 2012

International Classifications

C07K 16/10 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/145 Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/028946 Priority application(s): WO2008/028946

4 October 2012 Application Accepted

  Published as AU-B-2007293662

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007293667-Tasteless nutritional supplement containing free amino acids

2007293653-N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions